Filing Details
- Accession Number:
- 0000950170-24-092170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-06 19:56:12
- Reporting Period:
- 2024-08-02
- Accepted Time:
- 2024-08-06 19:56:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1701108 | Spero Therapeutics Inc. | SPRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1782817 | Sath Shukla | C/O Spero Therapeutics, Inc. 675 Massachusetts Avenue, 14Th Floor Cambridge MA 02139 | Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-02 | 14,800 | $1.32 | 1,161,207 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-08-05 | 17,641 | $1.31 | 1,143,566 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of RSUs that were granted to the Reporting Person on August 1, 2023 pursuant to a "sell to cover" provision included in each RSU Agreement.
Billionaire Hedge Funds
